Nevada
|
|
1-11151
|
|
76-0364866
|
(State or other jurisdiction
of incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
1300 West Sam Houston Parkway South,
Suite 300, Houston, Texas
|
|
77042
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 9.01
|
FINANCIAL STATEMENTS AND EXHIBITS
|
Exhibits
|
|
Description of Exhibits
|
99.1
|
|
U. S. Physical Therapy, Inc. Long-Term Incentive Plan for Senior Management for 2017, effective March 24, 2017.
|
99.2 | U. S. Physical Therapy, Inc. Discretionary Long-Term Incentive Plan for Senior Management for 2017, effective March 24, 2017. | |
99.3 | U. S. Physical Therapy, Inc. Objective Cash Bonus Plan for Senior Management for 2017, effective March 24, 2017 | |
99.4 | U. S. Physical Therapy, Inc. Discretionary Cash Bonus Plan for Senior Management for 2017, effective March 24, 2017 |
|
|
U.S. PHYSICAL THERAPY, INC.
|
||||
Dated: March 30, 2017
|
|
|
By:
|
|
/s/ LAWRANCE W. MCAFEE
|
|
|
|
|
Lawrance W. McAfee
|
|||
|
|
|
Chief Financial Officer
|
|||
|
|
|
(duly authorized officer and principal financial
and accounting officer)
|
$39,866,800 |
15.0%
|
$40,059,000 |
17.0%
|
$40,252,800 |
19.0%
|
$40,484,400 |
21.0%
|
$40,677,400 |
23.0%
|
$40,909,000 |
25.0%
|
$41,140,600 |
28.0%
|
$41,333,600 |
31.0%
|
$41,565,200 |
34.0%
|
$41,758.200 |
38.0%
|
$41,989,800 |
42.0%
|
$42,221,400 |
46.0%
|
$42,414,400 |
50.0%
|
$42,646,000 |
54.0%
|
$42,839,000 |
58.0%
|
$43,070,600 |
62.0%
|
$43,302,200 |
66.0%
|
$43,495,200 |
70.0%
|
$43,726,800 and over |
75.0%
|
1.
|
General operational management effectiveness relative to external environment
|
2.
|
Growth in earnings power and cash flow from operations
|
3.
|
Accretive acquisitions
|
4.
|
Clinic productivity and efficiency improvements
|
5.
|
Initiatives to enhance the overall quality of patient care
|
6.
|
Manage organic growth in our existing business segments
|
7.
|
Development of add-ons and/or new services that compliment or enhance existing business.
|
8.
|
Creative and effective sales and marketing
|
9.
|
Same store growth
|
10.
|
Regulatory compliance
|
11.
|
Maintaining adequate internal controls
|
12.
|
Management development and succession planning
|
13.
|
Corporate productivity and efficiency improvements
|
14.
|
Dividends, share repurchases and other effective means to deploy capital
|
15.
|
Investor relations and communication
|
16.
|
Cash flow, including management of accounts receivables
|
17.
|
Stock price performance
|
$39,866,800 |
15.0%
|
$40,059,000 |
17.0%
|
$40,252,800 |
19.0%
|
$40,484,400 |
21.0%
|
$40,677,400 |
23.0%
|
$40,909,000 |
25.0%
|
$41,140,600 |
28.0%
|
$41,333,600 |
31.0%
|
$41,565,200 |
34.0%
|
$41,758.200 |
38.0%
|
$41,989,800 |
42.0%
|
$42,221,400 |
46.0%
|
$42,414,400 |
50.0%
|
$42,646,000 |
54.0%
|
$42,839,000 |
58.0%
|
$43,070,600 |
62.0%
|
$43,302,200 |
66.0%
|
$43,495,200 |
70.0%
|
$43,726,800 and over |
75.0%
|
1.
|
General operational management effectiveness relative to external environment
|
2.
|
Growth in earnings power and cash flow from operations
|
3.
|
Accretive acquisitions
|
4.
|
Clinic productivity and efficiency improvements
|
5.
|
Initiatives to enhance the overall quality of patient care
|
6.
|
Manage organic growth in our existing business segment
|
7.
|
Development of add-ons and/or new services that compliment or enhance existing business.
|
8.
|
Creative and effective sales and marketing
|
9.
|
Same store growth
|
10.
|
Regulatory compliance
|
11.
|
Maintaining adequate internal controls
|
12.
|
Management development and succession planning
|
13.
|
Corporate productivity and efficiency improvements
|
14.
|
Dividends, share repurchases and other effective means to deploy capital
|
15.
|
Investor relations and communication
|
16.
|
Cash flow, including management of accounts receivables
|
17.
|
Stock price performance
|